Growing clinical awareness and emerging research suggest that many women experience worsening attention, executive dysfunction, and emotional regulation difficulties during perimenopause. These symptoms are frequently described as “brain fog,” forgetfulness, mental fatigue, and reduced concentration—features that overlap significantly with Attention-Deficit/Hyperactivity Disorder (ADHD).
While perimenopause does not cause ADHD, it represents a neuroendocrine transition that may exacerbate pre-existing cognitive vulnerabilities or unmask previously compensated ADHD traits due to hormonal fluctuations, sleep disruption, and increased psychosocial demands (Maki & Jaff, 2022).
Perimenopause is the transitional period before menopause characterized by fluctuating ovarian hormones, especially estradiol, irregular menstrual cycles, vasomotor symptoms, sleep disturbance, and mood changes (Santoro, 2016).
This phase can last 4–10 years and is associated with neurological and cognitive changes due to endocrine variability.
ADHD is a neurodevelopmental disorder with onset in childhood and persistence into adulthood for many individuals. Core features include inattention, executive dysfunction, impulsivity, and emotional dysregulation (American Psychiatric Association, 2022).
Importantly, ADHD in women is historically underdiagnosed, particularly in inattentive presentations, meaning midlife symptom worsening may reflect long-standing but previously compensated ADHD.
Research consistently shows that the menopausal transition is associated with changes in:
(Maki et al., 2010; Weber et al., 2014)
Longitudinal data from the Study of Women’s Health Across the Nation (SWAN) found modest declines in verbal memory and processing speed during perimenopause, though most performance remains within normative ranges (Greendale et al., 2009).
However, subjective cognitive complaints (brain fog, distractibility, mental overload) are often more pronounced than objective test findings.
Perimenopause is also associated with:
These features closely mirror emotional regulation challenges commonly observed in adults with ADHD.
Estradiol plays a significant role in cognitive functioning, particularly in the prefrontal cortex and hippocampus—regions responsible for attention, working memory, and executive control (Brinton et al., 2015).
Fluctuating estrogen levels during perimenopause are associated with:
(Maki & Jaff, 2022)
Estrogen modulates multiple neurotransmitter systems involved in ADHD, including:
(Shanmugan & Epperson, 2014)
This provides a biologically plausible explanation for why ADHD symptoms may intensify during hormonal transitions, even though ADHD itself is not hormonally caused.
Many women report that ADHD symptoms appear “suddenly” in their 40s. Clinically, this is more accurately understood as an unmasking phenomenon driven by:
Rather than late-onset ADHD, midlife often reveals long-standing executive vulnerabilities under increased neurological and environmental stress.
If your focus, memory, or executive functioning suddenly feel worse during perimenopause, you are not imagining it. Hormonal changes, sleep disruption, and increased stress load can all affect the same brain systems involved in attention and emotional regulation.
The most effective approach is usually not just one treatment, but a combination of medical, lifestyle, and supportive strategies.
If you already have ADHD, your usual medication may still work during perimenopause. However, some women notice their symptoms fluctuate more due to hormonal changes.
Common options include:
In some cases, medication adjustments may help if focus or emotional regulation suddenly worsens during midlife.
Always discuss changes with a qualified medical provider.
Hormone therapy is not a treatment for ADHD, but for some women it can help improve:
Research shows that stabilizing hormone levels during the menopausal transition may reduce some cognitive symptoms for certain individuals, though results vary person to person.
This decision should always be made with a medical professional based on your health history.
Poor sleep is one of the biggest reasons ADHD symptoms worsen during perimenopause.
Night sweats, insomnia, and hormonal shifts can lead to:
Helpful sleep supports include:
Even small improvements in sleep can significantly improve attention and executive functioning.
(Talk with a provider before starting any supplement)
Omega-3s are one of the most researched supplements for brain health and attention.
They may support:
Magnesium may help with:
Better sleep and lower stress often lead to improved focus and less mental fatigue.
Low iron or B12 can cause symptoms that look like ADHD, including:
Midlife is a common time for deficiencies, so lab testing can be helpful if symptoms suddenly worsen.
Many people do not realize that unstable blood sugar can worsen:
Helpful strategies:
Stable energy = more stable focus.
Regular movement supports:
You do not need extreme workouts. Even:
can improve attention and mental clarity over time.
Red and near-infrared light therapy is being studied for brain energy and cognitive fatigue.
Some early research suggests it may support:
However, this is still an emerging treatment and should be considered supportive, not a primary solution.
Natural sunlight (especially in the morning) helps regulate:
This can be especially helpful if fatigue and brain fog are prominent.
During perimenopause, your brain may have less internal bandwidth, which means external supports become more important.
Helpful strategies:
This is not “losing discipline.”
It is adapting to a changing neurological load.
Chronic stress worsens both hormonal symptoms and ADHD executive dysfunction.
Helpful approaches:
Lower stress often leads to clearer thinking and better emotional regulation.
Many women are first recognized as having ADHD during perimenopause because their previous coping strategies stop working.
Support options:
Understanding what is happening neurologically can reduce shame and self-blame.
Perimenopause does not cause ADHD.
However, it can make existing attention, memory, and emotional regulation challenges feel significantly more intense.
For many women, this stage is less about “sudden decline” and more about:
With the right supports, symptoms can become much more manageable.
The overlap between perimenopause and ADHD represents a clinically significant intersection of neurodevelopmental and neuroendocrine processes. Current research supports that the menopausal transition is associated with changes in attention, memory, and executive functioning, largely influenced by hormonal fluctuation, sleep disturbance, and stress load.
Perimenopause does not cause ADHD; however, it can intensify existing attentional and executive vulnerabilities and unmask previously compensated symptoms. A holistic treatment approach that integrates medical care, sleep stabilization, behavioral supports, and lifestyle interventions offers the most effective pathway for managing symptoms during this life stage.
This content is for educational and informational purposes only and does not constitute medical, psychological, or psychiatric advice. It is not intended to diagnose, treat, cure, or prevent any condition. Individuals experiencing significant cognitive, mood, hormonal, or attentional changes should consult a qualified healthcare provider, psychologist, psychiatrist, or medical professional for personalized evaluation and treatment.
American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.).
Baker, F. C., Lampio, L., Saaresranta, T., & Polo-Kantola, P. (2018). Sleep and sleep disorders in the menopausal transition. Sleep Medicine Clinics, 13(3), 443–456.
Brinton, R. D., Yao, J., Yin, F., Mack, W. J., & Cadenas, E. (2015). Perimenopause as a neurological transition state. Nature Reviews Endocrinology, 11(7), 393–405.
Greendale, G. A., et al. (2009). Cognitive aging in the menopause transition: Results from the Study of Women’s Health Across the Nation. Menopause, 16(6), 1115–1122.
Maki, P. M. (2013). Critical window hypothesis of hormone therapy and cognition. Menopause, 20(6), 695–709.
Maki, P. M., & Jaff, N. G. (2022). Cognitive changes during the menopause transition. Menopause, 29(9), 1–12.
Maki, P. M., et al. (2010). Verbal memory and executive function across the menopausal transition. Neurology, 74(2), 112–120.
Santoro, N. (2016). Perimenopause: From research to practice. Journal of Women’s Health, 25(4), 332–339.
Shanmugan, S., & Epperson, C. N. (2014). Estrogen and the prefrontal cortex: Implications for cognitive and psychiatric disorders. Frontiers in Neuroendocrinology, 35(2), 226–238.
Stillman, C. M., et al. (2020). Physical activity and cognitive function across the lifespan. Annual Review of Psychology, 71, 619–645.